Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Divestments (2022 - 2025)

Bio-Techne (TECH) has 8 years of Divestments data on record, last reported at $1.4 million in Q3 2025.

  • For Q3 2025, Divestments fell 3.71% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $2.6 million, up 85.39%, while the annual FY2023 figure was $17.8 million, N/A changed from the prior year.
  • Divestments reached $1.4 million in Q3 2025 per TECH's latest filing, up from $1.2 million in the prior quarter.
  • Across five years, Divestments topped out at $17.8 million in Q3 2022 and bottomed at $1.2 million in Q1 2025.
  • Average Divestments over 4 years is $4.8 million, with a median of $1.4 million recorded in 2024.
  • Peak YoY movement for Divestments: plummeted 87.94% in 2023, then dropped 3.71% in 2025.
  • A 4-year view of Divestments shows it stood at $17.8 million in 2022, then tumbled by 87.94% to $2.1 million in 2023, then tumbled by 34.71% to $1.4 million in 2024, then decreased by 3.71% to $1.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Divestments were $1.4 million in Q3 2025, $1.2 million in Q1 2025, and $1.4 million in Q3 2024.